Figure 4
Probability of relapse-free survival in patients with secondary and de novo MDS/tAML (unadjusted P = .03). Censored indicates censored data of patients alive and in remission at date of last contact.
Probability of relapse-free survival in patients with secondary and de novo MDS/tAML (unadjusted P = .03). Censored indicates censored data of patients alive and in remission at date of last contact.
